Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats

Area of Science:

• Neuroscience
• Regenerative Medicine
• Pharmacology

Background:

• Spinal cord injury (SCI) creates a growth-inhibitory environment, hindering central nervous system (CNS) neuron regeneration.
• Microtubule-stabilizing drugs like paclitaxel and epothilone B (Epo B) have shown potential in reducing scar formation and promoting axonal growth after SCI.
• Systemic Epo B administration has previously improved functional recovery in SCI models.

Purpose of the Study:

• To investigate the effects of epothilone D (Epo D), a novel analog of Epo B, on fibrotic scarring, axonal sprouting, and functional recovery after SCI.
• To evaluate Epo D's therapeutic potential as a systemic treatment for spinal cord injury.

Main Methods:

• Delayed systemic administration of Epo D in female Fischer 344 rats following a moderate contusion SCI (150 kDyn).
• Assessment of functional recovery using horizontal ladder walking, BBB open field locomotor rating scale, and Catwalk gait analysis.
• Histological evaluation of laminin-positive fibrotic scar tissue and 5-HT-positive serotonergic fiber length caudal to the lesion site.

Main Results:

• Epo D treatment led to a reduced number of footfalls in the horizontal ladder test at 4 and 8 weeks post-injury, indicating improved motor coordination.
• No significant alterations were observed in hindlimb motor function as assessed by the BBB scale or Catwalk gait analysis.
• Epo D did not significantly affect the formation of laminin-positive fibrotic scar tissue or the length of 5-HT-positive serotonergic fibers distal to the injury site.

Conclusions:

• Systemic administration of Epo D after SCI provides a functional motor benefit, specifically in fine motor coordination tasks.
• Despite functional improvements, Epo D did not significantly impact key SCI pathological markers such as scar formation or axonal regeneration.
• These findings support the recapitulation of functional benefits from systemic microtubule-stabilizing drug administration in a rat contusion SCI model.